H-CGKRK-OH

Ref. 3D-PP46126

Informations sur le produit

• Nom: H-CGKRK-OH
• Synonymes: NH2-Cys-Gly-Lys-Arg-Lys-OH

Description

Peptide H-CGKRK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-CGKRK-OH include the following: Self-assembly of cytotoxic peptide conjugated poly (beta-amino ester) s for synergistic cancer chemotherapy ZY Qiao , CY Hou, D Zhang , Y Liu, YX Lin - Journal of Materials , 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/tb/c4tb02144d Tumor homing peptides as fusion partners of therapeutic proteins for efficient delivery to cancer cells YE Lee, BH Hwang - Biotechnology and Bioprocess Engineering, 2023 - Springerhttps://link.springer.com/article/10.1007/s12257-022-0139-0 Multifunctional theranostic nanoparticles for brain tumors Y Wang , L Huang - Molecular Therapy, 2012 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30443-9 Optimization and internalization mechanisms of PEGylated adenovirus vector with targeting peptide for cancer gene therapy XL Yao, Y Yoshioka, GX Ruan , YZ Chen - , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bm300665u pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy XJ Liang - academia.eduhttps://www.academia.edu/download/73439834/C6RA27054A.pdf Tumor-penetrating peptides T Teesalu , KN Sugahara, E Ruoslahti - Frontiers in oncology, 2013 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fonc.2013.00216/full Rapid chelator-free radiolabeling of quantum dots for in vivo imaging T Tang , Y Wei , Q Yang , Y Yang, MJ Sailor , HB Pang - Nanoscale, 2019 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2019/nr/c9nr08508d Cancer-targeted delivery systems based on peptides T Chatzisideri, G Leonidis , V Sarli - Future Medicinal Chemistry, 2018 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/fmc-2018-0174 Au-CGKRK nanoconjugates for combating cancer through T-cell-driven therapeutic RNA interference SK Gulla , R Kotcherlakota, S Nimushakavi - ACS , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.8b01051 Tumor-penetrating nanosystem strongly suppresses breast tumor growth S Sharma, VR Kotamraju, T Molder, A Tobi - Nano , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.nanolett.6b03815 Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment S Sharma, AP Mann , T Mölder, VR Kotamraju - Journal of Controlled , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365917308933 Peptide based molecules as protein-protein interaction inhibitors: Tools for chemical genetics and therapy S Roy, P Ghosh, N Sekhar Roy - Current Chemical , 2012 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ccb/2012/00000006/00000002/art00006 Double-chambered ferritin platform: dual-function payloads of cytotoxic peptides and fluorescent protein S Kim , GS Kim, J Seo, G Gowri Rangaswamy - , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biomac.5b01134 CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels Q Hu , X Gao, T Kang, X Feng, D Jiang, Y Tu, Q Song - Biomaterials, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961213010727 Tumor microenvironment and angiogenic blood vessels dual-targeting for enhanced anti-glioma therapy Q Hu , T Kang, J Feng, Q Zhu, T Jiang - applied materials & , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsami.6b08239 Synthesis, characterization, and cytotoxicity evaluation of dextran-myristoyl-ECGKRK peptide conjugate NS El-Sayed , MI Sajid , K Parang , RK Tiwari - International Journal of , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813021020894 Synthesis, characterization, and in vitro cytotoxicity of fatty acyl-CGKRK-chitosan oligosaccharides conjugates for siRNA delivery NS El-Sayed , M Sharma , HM Aliabadi - International journal of , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0141813017332166 Tumor-targeted delivery of siRNA using fatty acyl-CGKRK peptide conjugates M Sharma , NS El-Sayed , H Do, K Parang , RK Tiwari - Scientific Reports, 2017 - nature.comhttps://www.nature.com/articles/s41598-017-06381-y Improving anti-tumour efficacy of PEGylated liposomal doxorubicin by dual targeting of tumour cells and tumour endothelial cells using anti-p32 CGKRK peptide M Mashreghi , M Faal Maleki , M Karimi - Journal of drug , 2021 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/1061186X.2020.1870230 Enhanced antiglioblastoma efficacy of neovasculature and glioma cells dual targeted nanoparticles L Lv, Y Jiang, X Liu, B Wang, W Lv, Y Zhao - Molecular , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.6b00523 Enhanced anti-glioma efficacy by borneol combined with CGKRK-modified paclitaxel self-assembled redox-sensitive nanoparticles L Lv, X Li, W Qian, S Li, Y Jiang, Y Xiong, J Xu - Frontiers in , 2020 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fphar.2020.00558/full Peptide-modified nanoparticles for tumor targeting and molecular imaging L Lu, Q Zhang, Z Wang, L Gao - Current Medicinal , 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2021/00000028/00000031/art00009 Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32 L Agemy, VR Kotamraju, D Friedmann-Morvinski - Molecular Therapy, 2013 - cell.comhttps://www.cell.com/molecular-therapy-family/molecular-therapy/fulltext/S1525-0016(16)30945-5 Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma L Agemy, D Friedmann-Morvinski - Proceedings of the , 2011 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1114518108 Cell-penetrating peptide CGKRK mediates efficient and widespread targeting of bladder mucosa following focal injury JI Griffin, SKK Cheng, T Hayashi, D Carson - , Biology and Medicine, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1549963417300655 Tumour-homing peptides: tools for targeting, imaging and destruction J Enback, P Laakkonen - Biochemical Society Transactions, 2007 - portlandpress.comhttps://portlandpress.com/biochemsoctrans/article-abstract/35/4/780/64142 Synergy of iron chelators and therapeutic peptide sequences delivered via a magnetic nanocarrier GS Abayaweera, H Wang, TB Shrestha , J Yu - Journal of Functional , 2017 - mdpi.comhttps://www.mdpi.com/2079-4983/8/3/23 Peptides as targeting elements and tissue penetration devices for nanoparticles E Ruoslahti - Advanced materials, 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/adma.201200454 Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides AR Mäkelä, H Matilainen, DJ White - Journal of , 2006 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.00528-06 Translational use of homing peptides: Tumor and placental targeting AA Alobaid, MWA Skoda , LK Harris - Journal of Colloid and , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021979724003473 pH-sensitive polymeric micelles for the Co-delivery of proapoptotic peptide and anticancer drug for synergistic cancer therapy A Mozhi , I Ahmad , CI Okeke, C Li, XJ Liang - RSC advances, 2017 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2017/ra/c6ra27054a Tumor-homing peptides as tools for targeted delivery of payloads to the placenta A King, C Ndifon, S Lui, K Widdows, VR Kotamraju - Science , 2016 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.1600349

• Marque: Biosynth